tradingkey.logo

Embecta Corp

EMBC
View Detailed Chart
13.420USD
+0.080+0.60%
Close 11/03, 16:00ETQuotes delayed by 15 min
784.71MMarket Cap
9.39P/E TTM

Embecta Corp

13.420
+0.080+0.60%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.60%

5 Days

-4.62%

1 Month

-6.28%

6 Months

+5.42%

Year to Date

-35.01%

1 Year

-5.82%

View Detailed Chart

TradingKey Stock Score of Embecta Corp

Currency: USD Updated: 2025-11-03

Key Insights

The company's fundamentals are relatively healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Hold. Despite an average stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Embecta Corp's Score

Industry at a Glance

Industry Ranking
61 / 210
Overall Ranking
154 / 4617
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 4 analysts
Hold
Current Rating
16.667
Target Price
+24.94%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Embecta Corp Highlights

StrengthsRisks
Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.72%.
Undervalued
The company’s latest PE is 9.34, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 60.03M shares, decreasing 5.12% quarter-over-quarter.
Held by Keeley-Teton Advisors, LLC
Star Investor Keeley-Teton Advisors, LLC holds 317.48K shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Embecta Corp Info

Embecta Corp. is a global medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. The Company has a portfolio of marketed products, including a variety of pen needles, syringes and safety injection devices. Its pen needles are sterile, single-use, medical devices, designed to be used in conjunction with pen injectors that inject insulin or other diabetes medications. It also sells safety pen needles, which have shields on both ends of the cannula that automatically deploy after the injection to help prevent needlestick exposure and injury during injection and disposal. Its traditional and safety pen needles are compatible and frequently used with pen injectors in the market. It sells sterile, single-use insulin syringes, which are used to inject insulin drawn from insulin vials. It also sells safety insulin syringes. It distributes its products through a variety of channels, including retail, hospitals and pharmacies.
Ticker SymbolEMBC
CompanyEmbecta Corp
CEOMr. Devdatt (Dev) Kurdikar
Websitehttps://www.embecta.com/
KeyAI